(Q43497738)

English

BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer

scientific article published on 16 July 2013

Statements

BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer (English)
Fatima Valdes-Mora
C Marcelo Sergio
David Gallego-Ortega
C Elizabeth Caldon
Christopher J Ormandy
Robert I Nicholson
Elizabeth A Musgrove

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit